Students listen as automation engineer Darby Nelson (not pictured) shows how electricity and magnets can work together to levitate samples on these rectangular movers in order to avoid any friction, which decreases wear and tear on machinery.
ARUP is using Deep Bio’s artificial intelligence-based software in research to evaluate how use of the software may aid in detection and classification of prostate cancer cells, such as the cells pictured here.
During the pandemic, ARUP hired more people than ever before to fill positions in labs associated with COVID-19 testing. When one of these labs, the Rapid Response Lab, closed, ARUP worked with a hundred employees to help them find other jobs within the company.
A donor collection specialist at the ARUP Blood Services Donor Center in Sandy bandages a donor’s arm after she has finished donating blood. ARUP is seeking donations of O-positive and O-negative blood to help address a critical shortage.
President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.
A former employee chats with CEO Sherrie L. Perkins, MD, PhD (center), during a reception on June 24, 2021, to celebrate Perkins’ retirement after 31 years at ARUP and the University of Utah.
New Infectious Diseases Society of America guidelines, authored by a panel led by ARUP’s Kimberly Hanson, MD, MHS, describe the benefits and limitations of COVID-19 rapid antigen testing. The expert panel suggests that standard nucleic acid amplification testing should be used instead of rapid antigen tests in most circumstances when possible.